Celularity Stock Annual Yield

CELUW Stock

USD 0.06 0.01 16.53%

Celularity fundamentals help investors to digest information that contributes to Celularity's financial success or failures. It also enables traders to predict the movement of Celularity Stock. The fundamental analysis module provides a way to measure Celularity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celularity stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Celularity Company Annual Yield Analysis

Celularity's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.

Yield

Income from Security

Current Share Price

More About Annual Yield | All Equity Analysis

Celularity Annual Yield Driver Correlations

Understanding the fundamental principles of building solid financial models for Celularity is extremely important. It helps to project a fair market value of Celularity Stock properly, considering its historical fundamentals such as Annual Yield. Since Celularity's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Celularity's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Celularity's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Common Stock	Net Tangible Assets	Accounts Payable	Net Receivables	Good Will	Capital Surpluse	Intangible Assets	Current Deferred Revenue	Short Term Investments	Deferred Long Term Liab	Net Invested Capital	Capital Stock	Net Working Capital	Short Term Debt	Short Long Term Debt
Total Assets		-0.06	0.31	-0.73	0.71	0.86	0.24	-0.76	0.39	0.5	-0.22	0.77	-0.63	-0.64	-0.24	-0.24	0.62	0.48	-0.41	0.35	0.17
Total Stockholder Equity	-0.06		0.52	0.05	-0.73	-0.52	0.41	0.1	0.1	-0.03	-0.1	-0.14	0.04	-0.34	-0.09	-0.09	0.34	0.29	-0.26	0.26	0.1
Net Debt	0.31	0.52		-0.63	-0.22	0.12	0.13	-0.62	0.67	0.73	-0.8	0.47	-0.7	-0.72	-0.71	-0.71	0.76	0.79	-0.9	0.86	0.77
Retained Earnings	-0.73	0.05	-0.63		-0.48	-0.76	0.2	0.99	-0.85	-0.91	0.76	-0.95	0.98	0.9	0.53	0.53	-0.9	-0.89	0.85	-0.78	-0.61
Total Liab	0.71	-0.73	-0.22	-0.48		0.92	-0.09	-0.53	0.15	0.32	0.01	0.61	-0.39	-0.15	0.03	0.03	0.14	0.1	-0.03	0.03	-0.03
Total Current Assets	0.86	-0.52	0.12	-0.76	0.92		-0.16	-0.81	0.43	0.59	-0.28	0.83	-0.68	-0.51	-0.23	-0.23	0.5	0.44	-0.38	0.33	0.23
Common Stock	0.24	0.41	0.13	0.2	-0.09	-0.16		0.2	-0.16	-0.17	0.13	-0.19	0.19	0.17	0.09	0.09	-0.17	-0.17	0.16	-0.14	-0.11
Net Tangible Assets	-0.76	0.1	-0.62	0.99	-0.53	-0.81	0.2		-0.83	-0.91	0.73	-0.95	0.97	0.88	0.57	0.57	-0.87	-0.86	0.82	-0.75	-0.66
Accounts Payable	0.39	0.1	0.67	-0.85	0.15	0.43	-0.16	-0.83		0.94	-0.89	0.8	-0.91	-0.79	-0.52	-0.52	0.8	0.93	-0.85	0.83	0.81
Net Receivables	0.5	-0.03	0.73	-0.91	0.32	0.59	-0.17	-0.91	0.94		-0.88	0.87	-0.96	-0.79	-0.56	-0.56	0.81	0.92	-0.91	0.9	0.81
Good Will	-0.22	-0.1	-0.8	0.76	0.01	-0.28	0.13	0.73	-0.89	-0.88		-0.59	0.87	0.67	0.74	0.74	-0.69	-0.82	0.89	-0.8	-0.87
Capital Surpluse	0.77	-0.14	0.47	-0.95	0.61	0.83	-0.19	-0.95	0.8	0.87	-0.59		-0.9	-0.82	-0.3	-0.3	0.83	0.84	-0.73	0.73	0.51
Intangible Assets	-0.63	0.04	-0.7	0.98	-0.39	-0.68	0.19	0.97	-0.91	-0.96	0.87	-0.9		0.86	0.63	0.63	-0.87	-0.91	0.9	-0.82	-0.73
Current Deferred Revenue	-0.64	-0.34	-0.72	0.9	-0.15	-0.51	0.17	0.88	-0.79	-0.79	0.67	-0.82	0.86		0.52	0.52	-0.99	-0.93	0.85	-0.78	-0.58
Short Term Investments	-0.24	-0.09	-0.71	0.53	0.03	-0.23	0.09	0.57	-0.52	-0.56	0.74	-0.3	0.63	0.52		1.0	-0.49	-0.49	0.63	-0.45	-0.81
Deferred Long Term Liab	-0.24	-0.09	-0.71	0.53	0.03	-0.23	0.09	0.57	-0.52	-0.56	0.74	-0.3	0.63	0.52	1.0		-0.49	-0.49	0.63	-0.45	-0.81
Net Invested Capital	0.62	0.34	0.76	-0.9	0.14	0.5	-0.17	-0.87	0.8	0.81	-0.69	0.83	-0.87	-0.99	-0.49	-0.49		0.95	-0.89	0.83	0.57
Capital Stock	0.48	0.29	0.79	-0.89	0.1	0.44	-0.17	-0.86	0.93	0.92	-0.82	0.84	-0.91	-0.93	-0.49	-0.49	0.95		-0.94	0.93	0.72
Net Working Capital	-0.41	-0.26	-0.9	0.85	-0.03	-0.38	0.16	0.82	-0.85	-0.91	0.89	-0.73	0.9	0.85	0.63	0.63	-0.89	-0.94		-0.96	-0.75
Short Term Debt	0.35	0.26	0.86	-0.78	0.03	0.33	-0.14	-0.75	0.83	0.9	-0.8	0.73	-0.82	-0.78	-0.45	-0.45	0.83	0.93	-0.96		0.71
Short Long Term Debt	0.17	0.1	0.77	-0.61	-0.03	0.23	-0.11	-0.66	0.81	0.81	-0.87	0.51	-0.73	-0.58	-0.81	-0.81	0.57	0.72	-0.75	0.71

Click cells to compare fundamentals

Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.

Competition

Predict Celularity

In accordance with the recently published financial statements, Celularity has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Idea Optimizer Now

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio

All Next

Launch Module

Celularity Fundamentals

	Return On Equity	-1.47
	Return On Asset	-0.17
	Profit Margin	(0.73) %
	Operating Margin	(1.24) %
	Number Of Shares Shorted	174.36 K
	Revenue	22.77 M
	Gross Profit	30.95 M
	EBITDA	(183.95 M)
	Net Income	(196.29 M)
	Cash And Equivalents	38 M
	Cash Per Share	0.27 X
	Total Debt	65.42 M
	Debt To Equity	0.18 %
	Current Ratio	2.29 X
	Book Value Per Share	0.79 X
	Cash Flow From Operations	(38.69 M)
	Earnings Per Share	(0.87) X
	Number Of Employees	120
	Beta	0.63
	Total Asset	143.89 M
	Retained Earnings	(841.79 M)
	Working Capital	(47.51 M)
	Net Asset	143.89 M

About Celularity Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Celularity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celularity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celularity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC